SIGLEC12 and cancer: In contrast, in a multi‐tissue array from the same source with multiple malignancies, we found an abundance of expression in carcinomas (malignancies arising from epithelia) (see examples in Figure 2A), with a much higher than expected frequency of Siglec‐XII in cancers (~80%) as compared to normal tissue (Figure 2B,C).